Xiangrui Liu
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 29
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 23
- Graphene and Nanomaterials Applications 7
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 32
- Advanced biosensing and bioanalysis techniques 16
- Pharmaceutical Science top 2%
- Oncology top 5%
- Cancer-related Molecular Pathways 8
-
- Dendrimers and Hyperbranched Polymers 12
-
- Virus-based gene therapy research 9
Xiangrui Liu
116 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Biomaterials 1.6k
- Biomedical Engineering 2.0k
- Molecular Biology 2.4k
- Pharmaceutical Science 198
- Oncology 746
Countries citing papers authored by Xiangrui Liu
This map shows the geographic impact of Xiangrui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangrui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangrui Liu more than expected).
Fields of papers citing papers by Xiangrui Liu
This network shows the impact of papers produced by Xiangrui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangrui Liu. The network helps show where Xiangrui Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangrui Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 18 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 4 | |
| 13 | Development of a Novel MR Colonography via Iron-Based Solid Lipid Nanoparticles | 2022 | 4 |
| 14 | 2022 | 19 | |
| 15 | 2021 | 7 | |
| 16 | 2020 | 17 | |
| 17 | 2018 | 31 | |
| 18 | Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integrationbreakdown → | 2017 | 332 |
| 19 | 2015 | 78 | |
| 20 | 2012 | 60 |
About Xiangrui Liu
Xiangrui Liu is a scholar working on Biomaterials, Energy Engineering and Power Technology and Polymers and Plastics, having authored 121 papers that have together received 4.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (32 papers), Nanoparticle-Based Drug Delivery (29 papers), Nanoplatforms for cancer theranostics (23 papers), Advanced biosensing and bioanalysis techniques (16 papers), Dendrimers and Hyperbranched Polymers (12 papers), Virus-based gene therapy research (9 papers), Cancer-related Molecular Pathways (8 papers) and Graphene and Nanomaterials Applications (7 papers). The work is most often cited by research in Biomaterials (1.6k citations), Biomedical Engineering (2.0k citations) and Molecular Biology (2.4k citations). Xiangrui Liu has collaborated with scholars based in China, New Zealand and United Kingdom. Frequent co-authors include Youqing Shen, Zhuxian Zhou, Jianbin Tang, Ying Piao, Jiajia Xiang, Xuefei Zhou, Dingcheng Zhu, Quan Zhou, Jinqiang Wang and Jianbin Tang. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.